| Clinical features |
|
Symptoms
Increased sweatingHeadaches Tiredness and lethargy Joint pains Erectile dysfunction/amenorrhoea Change in ring or shoe size Signs
Facial appearance (compare with old photos)
Coarse features, frontal bossing, enlarged nose, prominent facial folds and wrinkling, large fleshy nose, prognathism, increased tooth separation and jaw malocclusion.
Skin tagsDeep voice Tongue enlargement Enlargement of hands and feet Goitre Effects of Tumour
Visual field defectsHypopituitarism Complications
HypertensionInsulin resistance and impaired glucose tolerance /diabetes mellitus Congestive cardiac failure Ischaemic heart disease and cerebrovascular disease Obstructive sleep apnoea Carpal tunnel syndrome |
Diagnostic Investigations:
Investigations at the time of referral to endocrine outpatients:
| IGF-1: | Almost invariably elevated in acromegaly |
NB Random Growth hormone estimates are not useful in the diagnosis of Acromegaly
| Baseline Pituitary function tests |
Further Investigations (to be arranged from Endocrine clinic):
| Urinary catecholamines: | If the patient is hypertensive |
| Glucose suppression test | In acromegaly, there is failure to suppress GH to <2mU/l in response to a 75g oral glucose load. In contrast, the normal response is GH suppression to undetectable levels. |
| MRI pituitary fossa | MRI usually demonstrates the tumour, and whether there is extrasellar extension either suprasellar or into the cavernous sinus |
| Visual Fields |
Follow Up
Follow up of Acromegaly - 5 Point GH Day Curve
Indications
Assessment of cure or adequacy of treatment in Acromegaly
Procedure
Non-fasting
Tablets: take all prescribed drugs including Octreotide at normal time
Measurements
1. Take blood for Growth Hormone and IGF-1 at 0900h. (red or gold top vial).
2. Take blood for Growth Hormone at 1100, 1300, 1500 and 1700h
Interpretation guidelines
Mean GH of <5mU/L indicates cure/ disease control